Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions

see the original item page
in the repository's web site and access all digital files if the item*



Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions (EN)

Solomon, M (EN)
Cabral, AR (EN)
Erkan, D (EN)
Vadya, S (EN)
Adrogue, HE (EN)
Shoenfeld, Y (EN)
Gonzalez, EB (EN)
Zandman-Goddard, G (EN)
Cervera, R (EN)
Tektonidou, MG (EN)
Espinosa, G (EN)

journalArticle (EN)

2014-03-01T02:07:07Z
2011 (EN)


The objectives of the 'Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations' were to assess the clinical utility of the international consensus statement on classification criteria and treatment guidelines for the catastrophic APS, to identify and grade the studies that analyse the relationship between the antiphospholipid antibodies and the non-criteria APS manifestations and to present the current evidence regarding the accuracy of these non-criteria APS manifestations for the detection of patients with APS. This article summarizes the studies analysed on the catastrophic APS, APS nephropathy and heart valve lesions, and presents the recommendations elaborated by the Task Force after this analysis. Lupus (2011) 20, 165-173. (EN)

Rheumatology (EN)

LONG-TERM (EN)
SYSTEMIC-LUPUS-ERYTHEMATOSUS (EN)
CARDIAC MANIFESTATIONS (EN)
ANTICARDIOLIPIN ANTIBODIES (EN)
TRANSESOPHAGEAL ECHOCARDIOGRAPHY (EN)
GLOMERULAR THROMBOSIS (EN)
VALVULAR DISEASE (EN)
Catastrophic antiphospholipid syndrome (EN)
antiphospholipid antibodies (EN)
INTERNATIONAL CONSENSUS STATEMENT (EN)
heart valve lesions (EN)
nephropathy (EN)
TRANSTHORACIC ECHOCARDIOGRAPHY (EN)
CLASSIFICATION CRITERIA (EN)

LUPUS (EN)

English

SAGE PUBLICATIONS LTD (EN)




*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)